Cargando…
The Pharmacokinetic-Pharmacodynamic Model of Azithromycin for Lipopolysaccharide-Induced Depressive-Like Behavior in Mice
A mechanism-based model was developed to describe the time course of lipopolysaccharide-induced depressive-like behavior and azithromycin pharmacodynamics in mice. The lipopolysaccharide-induced disease progression was monitored by lipopolysaccharide, proinflammatory cytokines, and kynrenine concent...
Autores principales: | Hao, Kun, Qi, Qu, Hao, Haiping, Wang, Guangji, Chen, Yuancheng, Liang, Yan, Xie, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554664/ https://www.ncbi.nlm.nih.gov/pubmed/23358536 http://dx.doi.org/10.1371/journal.pone.0054981 |
Ejemplares similares
-
Lipopolysaccharide Preconditioning Restricts Microglial Overactivation and Alleviates Inflammation-Induced Depressive-like Behavior in Mice
por: Yu, Haiping, et al.
Publicado: (2023) -
In vitro activity and pharmacodynamic/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections
por: Davidson, Ross J
Publicado: (2019) -
Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
por: Yang, Haijing, et al.
Publicado: (2022) -
The Role of Neutrophil Extracellular Traps in Lipopolysaccharide-Induced Depression-like Behaviors in Mice
por: Kong, Yue, et al.
Publicado: (2021) -
Dobutamine Alters the Pharmacokinetic and Pharmacodynamic Behavior of Esmolol
por: Krumpl, Günther, et al.
Publicado: (2020)